News & Updates

The tricyclic antidepressant amitriptyline, when used at low dose in the second-line treatment setting and titrated according to symptom response and side-effects, is safe and provides relief from symptoms of irritable bowel syndrome (IBS), as shown in the phase III ATLANTIS* trial.

Primary tumour resection (PTR) in combination with chemotherapy (C) appears beneficial to a specific subgroup of patients with unresectable colorectal mucinous adenocarcinoma with liver metastasis (UCR-MAC-LM) compared with PTR or C alone, suggests a study.

Researchers from the Chinese University of Hong Kong (CUHK) have demonstrated the potential application of two artificial intelligence (AI) tools, ENDO-AID and AI-Endo, for training endoscopists in early-stage gastrointestinal (GI) cancer management.